Excited to present our research looking at real-world irAEs in our early TNBC patient population @ASCO. Grateful for the mentorship of @JasmineSukumar and @CarlosHBarcenas! #ASCO24#bcsm
It’s official! So excited to have passed my #ABIM Internal Medicine Boards. Excited for the next chapter which will be Heme/Onc fellowship. #MedTwitter
Incredibly excited to present our current research looking at immune related adverse events in the non-metastatic TNBC population receiving pembrolizumab at the IOTOX Conference @MDAndersonNews. Super grateful for my mentors @CarlosHBarcenas and @JasmineSukumar!
Presented out abstract on using visual aids in patient education to improve retention of information across all literacy levels at #ASCOQLTY22. @ASCO@McGovernHemeOnc
If you ever request INR or APTT, this is for you. An one page summary of the key points published today by the @CMAJ. Although the authors are Canadian, the points made apply internationally. https://t.co/DhynNQ5r25
Dr. Sofia Mastoraki shares a novel prognostic tool that may help identify patients with early-stage ER positive/HER2 negative breast cancer that will benefit from long-term endocrine therapy: https://t.co/9hZlofDXuX @SofiaMast1@KellyKhunt@kandymarsy#AACR22#EndCancer
Nebraska’s very own @unmc expert Dr. Broadhurst talking about their #Covid_19 test they have developed that can have results in just a few hours, ensuring early detection and saving lives. #Nebraska